Pàgina inicial > Resultats de la cerca: Re, Alessandro
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
12 p, 600.5 KB A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma / Carlo-Stella, Carmelo (Humanitas Research Hospital (Itàlia)) ; Zinzani, Pier Luigi (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Sureda, Anna (Hospital Universitari de Bellvitge) ; Araújo, Luis (Universitário de Coimbra) ; Casasnovas, Olivier (CHU Dijon Bourgogne) ; Carpio Segura, Cecilia del Carmen (Hospital Universitari Vall d'Hebron) ; Yeh, Su-Peng (China Medical University Hospital) ; Bouabdallah, Krimo (University Hospital of Bordeaux) ; Cartron, Guillaume (Centre Hospitalier Universitaire Montpellier) ; Kim, Won Seog (Samsung Medical Center) ; Cordoba, Raul (Hospital Universitario Fundación Jiménez Díaz) ; Koh, Youngil (Seoul National University Hospital) ; Re, Alessandro (ASST Spedali Civili Brescia) ; Alves, Daniela (Centro Hospitalar Universitário Lisboa Norte) ; Chamuleau, Martine (Vrije Universiteit Amsterdam) ; Le Gouill, Steven (Institut Curie) ; López Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Moreira, Ilídia (Portuguese Institute of Oncology of Porto) ; van der Poel, Marjolein W. M. (Maastricht University Medical Center) ; Abbadessa, Giovanni (Sanofi) ; Meng, Robin (Sanofi) ; Ji, Ran (Sanofi) ; Lépine, Lucie (Sanofi) ; Saleem, Rao (Sanofi) ; Ribrag, Vincent (Institut Gustave Roussy (Villejuif, França)) ; Universitat Autònoma de Barcelona
Patients with relapsed or refractory lymphoma have limited treatment options, requiring newer regimens. In this Phase 1/2 study (NCT03769181), we assessed the safety, efficacy, and pharmacokinetics of isatuximab (Isa, anti-CD38 antibody) in combination with cemiplimab (Cemi, anti-programmed death-1 [PD-1] receptor antibody; Isa + Cemi) in patients with classic Hodgkin lymphoma (cHL), diffuse large B-cell lymphoma (DLBCL), and peripheral T-cell lymphoma (PTCL). [...]
2022 - 10.1002/hon.3089
Hematological Oncology, Vol. 41 (october 2022) , p. 108-119  
Registre complet - Creative Commons
2.
10 p, 578.0 KB Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma : a multicenter GELTAMO/FIL study / García-Sancho, Alejandro Martín (Hospital Universitario de Salamanca) ; Bellei, Monica (Fondazione Italiana Linfomi (FIL) Onlus, Modena, Italy) ; López-Parra, Miriam (Instituto de Investigación Biomédica de Salamanca) ; Gritti, Giuseppe (, ASST Papa Giovanni XXIII, Bergamo, Italy) ; Cortés, María (Department of Statistics, Hospital Universitario de Salamanca / IBSAL, Salamanca, Spain) ; Novelli, Silvana (Institut d'Investigació Biomèdica Sant Pau) ; Panizo, Carlos (Clínica Universidad de Navarra) ; Petrucci, Luigi (Sapienza University) ; Gutiérrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Dlouhy, Ivan (Hospital Clínic i Provincial de Barcelona) ; Bastos, Mariana (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Sancho, Juan M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ramírez, María J. (Hematology Department, Hospital de Especialidades de Jerez de la Frontera, Cádiz, Spain) ; Moraleda, José M. (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Carrillo, Estrella (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Jiménez-Ubieto, Ana I. (Hospital Universitario 12 de Octubre (Madrid)) ; Jarque, Isidro (Instituto de Investigación Sanitaria La Fe) ; Orsucci, Lorella (Candiolo Cancer Institute) ; García-Torres, Estefanía (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Montalbán, Carlos (Department of Translational Research, MD Anderson Cancer Center, Madrid, Spain) ; Dodero, Anna (Division of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy) ; Arranz, Reyes (Hospital Universitario de la Princesa (Madrid)) ; De las Heras, Natalia (Department of Hematology, Complejo Hospitalario de León, León, Spain) ; Pascual, María J. (Hospital Regional Universitario de Málaga) ; López-Jiménez, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ; Spina, Michelle (Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy) ; Re, Alessandro (Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy) ; de Villambrosia, Sonia González (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Bobillo, Sabela (Vall d'Hebron Institut d'Oncologia) ; Federico, Massimo (University of Modena and Reggio Emilia) ; Caballero, Dolores (Instituto de Investigación Biomédica de Salamanca) ; Universitat Autònoma de Barcelona
Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies that mostly have poor prognoses with currently available treatments. Upfront consolidation with autologous stem cell transplantation (ASCT) is frequently carried out, but its efficacy has never been investigated in randomized trials. [...]
2022 - 10.3324/haematol.2021.279426
Haematologica, Vol. 107 (march 2022) , p. 2675-2684  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Re, Alisa del
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem